Importantly, a recent study found that the expansion of CD57+KLRG1+ T cells in CMV+ young adults is associated with a reduced Ebola vaccine response (Bowyer et al., 2020), suggesting that CMV infection could also have negative impacts on vaccination efficacy. The gene discussed is B3GAT1; the disease is Ebola hemorrhagic fever.